ARPA-H Launches APECx Program to Transform Vaccine Discovery

The Advanced Research Projects Agency for Health (ARPA-H) launched a research program to develop a computational toolkit that helps design vaccines that target many viruses at once. The program is called the Antigens Predicted for Broad Viral Efficacy through Computational Experimentation, or APECx.

“Viruses continue to threaten our health security and impact American health outcomes so designing vaccines that are capable of protecting against many emerging threats at once is critical,” said ARPA-H APECx Program Manager Andy Kilianski, PhD. “We need to fundamentally shift the vaccine development paradigm to catch up to the many viruses we can’t prevent today. APECx strives to remove roadblocks by developing toolkits and vaccines in ways that are currently not possible.”